PBH · NYSE · CIK 0001295947
Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc.’s most recent SEC filing in our snapshot is a Form 8-K filed on Aug 14, 2026. In fiscal 2026 (year ended Mar 31, 2026) it reported revenue of $1.1B and net income of $190.3M, according to its XBRL data on EDGAR. Its EDGAR record lists 27 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Prestige Consumer Healthcare Inc.
- Ticker
- PBH
- SEC Central Index Key (CIK)
- 0001295947
- Industry (SIC)
- Pharmaceutical Preparations (code 2834)
- Business address
- TARRYTOWN, NY
- State or country of incorporation
- —
- Fiscal year ends
- March 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #1866 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Prestige Consumer Healthcare Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2022 ended Mar 31, 2022 | FY2023 ended Mar 31, 2023 | FY2024 ended Mar 31, 2024 | FY2025 ended Mar 31, 2025 | FY2026 ended Mar 31, 2026 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| Net income | $205.4M | -$82.3M | $209.3M | $214.6M | $190.3M |
| Diluted EPS | $4.04 | -$1.65 | $4.17 | $4.29 | $3.91 |
| Total assets | $3.7B | $3.4B | $3.3B | $3.4B | $3.5B |
| Cash and equivalents | $27.2M | $58.5M | $46.5M | $97.9M | $63.9M |
XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| May 14, 2026 | 10-K | Annual report· period Mar 31, 2026 | Document · Index |
| Aug 6, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 14, 2026 | 8-K | Director or officer change· period Aug 10, 2026 | Document · Index |
| Jun 29, 2026 | DEF 14A | Definitive proxy statement· period Jun 29, 2026 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about Prestige Consumer Healthcare Inc., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Aug 14, 2026 | 8-K | Director or officer change· period Aug 10, 2026 | Document · Index |
| Aug 6, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 6, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Aug 6, 2026 | Document · Index |
| Aug 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026 | Document · Index |
| Aug 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026 | Document · Index |
| Aug 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026 | Document · Index |
| Aug 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026 | Document · Index |
| Aug 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026 | Document · Index |
| Jul 15, 2026 | 8-K | Material agreement; New financial obligation· period Jul 15, 2026 | Document · Index |
| Jul 9, 2026 | 8-K/A | Current report· period Jun 12, 2026 | Document · Index |
| Jul 7, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Jul 6, 2026 | 8-K | Material agreement; New financial obligation; Regulation FD disclosure· period Jun 30, 2026 | Document · Index |
| Jun 30, 2026 | 8-K/A | Current report· period Jun 12, 2026 | Document · Index |
| Jun 29, 2026 | ARS | ANNUAL REPORT TO SECURITY HOLDERS· period Mar 31, 2026 | Document · Index |
| Jun 29, 2026 | DEF 14A | Definitive proxy statement· period Jun 29, 2026 | Document · Index |
| Jun 16, 2026 | 8-K | Material agreement; Acquisition or disposition completed; New financial obligation; Other events· period Jun 12, 2026 | Document · Index |
| May 14, 2026 | 10-K | Annual report· period Mar 31, 2026 | Document · Index |
| May 14, 2026 | 4/A | Statement of changes in beneficial ownership (insider trade)· period May 2, 2026 | Document · Index |
| May 13, 2026 | 8-K | Material agreement; Results of operations; Regulation FD disclosure· period May 13, 2026 | Document · Index |
| May 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 11, 2026 | Document · Index |
| May 11, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 7, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| May 7, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 5, 2026 | Document · Index |
| May 7, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 5, 2026 | Document · Index |
| May 7, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 5, 2026 | Document · Index |
| May 6, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| May 6, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 4, 2026 | Document · Index |
| May 6, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 4, 2026 | Document · Index |
| May 6, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 4, 2026 | Document · Index |
| May 6, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 4, 2026 | Document · Index |
| May 6, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 4, 2026 | Document · Index |
| May 5, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| May 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 2, 2026 | Document · Index |
| May 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 2, 2026 | Document · Index |
| May 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 2, 2026 | Document · Index |
| May 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 2, 2026 | Document · Index |
Insider filing activity
27 Form 4 filings appear in Prestige Consumer Healthcare Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Pharmaceutical Preparations
- LLY ELI LILLY & Co
- JNJ JOHNSON & JOHNSON
- ABBV AbbVie Inc.
- MRK Merck & Co., Inc.
- NVS NOVARTIS AG
- AZN ASTRAZENECA PLC
- ABT ABBOTT LABORATORIES
- NVO NOVO NORDISK A S
All 194 companies in Pharmaceutical Preparations· Companies headquartered in New York
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001295947 and XBRL company facts. Prestige Consumer Healthcare Inc. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement